Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Lymphoid Leukemias, ALL, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Lymphomas, Non-Hodgkin lymphoma, Drug development, Translational Research, LGL, Drug-drug interactions, Clinical Research, Health outcomes research, T Cell lymphoma, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Monoclonal Antibody Therapy, Survivorship, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous), Molecular testing
Type: Poster
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Lymphoid Leukemias, ALL, Combination therapy, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Lymphomas, Non-Hodgkin lymphoma, Drug development, Translational Research, LGL, Drug-drug interactions, Clinical Research, Health outcomes research, T Cell lymphoma, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Real-world evidence, Adverse Events, Lymphoid Malignancies, Monoclonal Antibody Therapy, Survivorship, Technology and Procedures, Study Population, Human, Measurable Residual Disease , Transplantation (Allogeneic and Autologous), Molecular testing
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH